Previous Article | Next Article 
Journal of Clinical Microbiology, June 2003, p. 2458-2464, Vol. 41, No. 6
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.6.2458-2464.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Genetic Relatedness of Levofloxacin-Nonsusceptible Streptococcus pneumoniae Isolates from North America
Crystal N. Johnson,1 William H. Benjamin, Jr.,1,2 Stephen A. Moser,1,2 Susan K. Hollingshead,1 Xiaotian Zheng,3 Marilyn J. Crain,1,4 Moon H. Nahm,1,2 and Ken B. Waites1,2*
Departments of Microbiology,1
Pathology,2
Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama,4
Diagnostic Laboratory Services and University of Hawaii, Honolulu, Hawaii3
Received 13 June 2002/
Returned for modification 16 July 2002/
Accepted 20 February 2003
We characterized 32 levofloxacin-nonsusceptible Streptococcus pneumoniae (LNSP) isolates obtained from a broad geographic region of North America over a 5-year period by using capsular serotypes, antimicrobial susceptibility profiles, BOX-PCR, multilocus sequence typing (MLST), and pulsed-field gel electrophoresis (PFGE). Sixteen international clones identified by the Pneumococcal Molecular Epidemiology Network also were included for comparison. Fifteen serotypes were represented, with serogroups 6, 9, 14, 19, and 23 accounting for 63% of isolates. Among isolates whose quinolone resistance-determining regions were sequenced, all contained gyrA and parC point mutations. Sixty-three percent were penicillin susceptible, and 84% were erythromycin susceptible. BOX-PCR analysis identified 39 different band patterns among 32 LNSP and 16 international clones and grouped 16 isolates, including 2 international clones, into seven unrelated groups of 2 to 4 isolates each. PFGE analysis identified 35 different band patterns among 32 LNSP and 16 international clones and grouped 21 isolates, including 3 international clones, into eight unrelated groups of 2 to 6 isolates each. MLST performed on 10 isolates identified five allelic profiles and separated 9 isolates into four groups of 2 to 3 isolates each. Overall, each typing method indicated that the LNSP were heterogeneous and that resistance to fluoroquinolones was not closely associated with a particular serotype or with coresistance to other antimicrobial classes and suggests that LNSP have likely arisen through independent mutational events as a result of selective pressure. However, seven LNSP were found to be related to three international clones by PFGE.
* Corresponding author. Mailing address: Department of Pathology, WP 230, 619 19th Street S., University of Alabama at Birmingham, Birmingham, AL 35249. Phone: (205) 934-0578. Fax: (205) 975-4468. E-mail: waites{at}path.uab.edu.
Journal of Clinical Microbiology, June 2003, p. 2458-2464, Vol. 41, No. 6
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.6.2458-2464.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Nichol, K. A., Adam, H. J., Karlowsky, J. A., Zhanel, G. G., Hoban, D. J.
(2008). Increasing Genetic Relatedness of Ciprofloxacin-Resistant Streptococcus pneumoniae Isolated in Canada from 1997 to 2005. Antimicrob. Agents Chemother.
52: 1190-1194
[Abstract]
[Full Text]
-
Davies, T. A., Yee, Y. C., Goldschmidt, R., Bush, K., Sahm, D. F., Evangelista, A.
(2006). Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999-2003). J Antimicrob Chemother
57: 437-442
[Abstract]
[Full Text]
-
Stanhope, M. J., Walsh, S. L., Becker, J. A., Italia, M. J., Ingraham, K. A., Gwynn, M. N., Mathie, T., Poupard, J. A., Miller, L. A., Brown, J. R., Amrine-Madsen, H.
(2005). Molecular Evolution Perspectives on Intraspecific Lateral DNA Transfer of Topoisomerase and Gyrase Loci in Streptococcus pneumoniae, with Implications for Fluoroquinolone Resistance Development and Spread. Antimicrob. Agents Chemother.
49: 4315-4326
[Abstract]
[Full Text]
-
Sadowy, E., Izdebski, R., Skoczynska, A., Gniadkowski, M., Hryniewicz, W.
(2005). High Genetic Diversity of Ciprofloxacin-Nonsusceptible Isolates of Streptococcus pneumoniae in Poland. Antimicrob. Agents Chemother.
49: 2126-2129
[Abstract]
[Full Text]
-
Reinert, R. R., Ringelstein, A., van der Linden, M., Cil, M. Y., Al-Lahham, A., Schmitz, F.-J.
(2005). Molecular Epidemiology of Macrolide-Resistant Streptococcus pneumoniae Isolates in Europe. J. Clin. Microbiol.
43: 1294-1300
[Abstract]
[Full Text]
-
Pletz, M. W. R., McGee, L., Jorgensen, J., Beall, B., Facklam, R. R., Whitney, C. G., Klugman, K. P.
(2004). Levofloxacin-Resistant Invasive Streptococcus pneumoniae in the United States: Evidence for Clonal Spread and the Impact of Conjugate Pneumococcal Vaccine. Antimicrob. Agents Chemother.
48: 3491-3497
[Abstract]
[Full Text]
-
Morrissey, I., Tillotson, G.
(2004). Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae. J Antimicrob Chemother
53: 144-148
[Abstract]
[Full Text]
-
Waites, K. B., Jones, K. E., Kim, K. H., Moser, S. A., Johnson, C. N., Hollingshead, S. K., Kang, E.-S., Hong, K. S., Benjamin, W. H. Jr.
(2003). Dissemination of Macrolide-Resistant Streptococcus pneumoniae Isolates Containing Both erm(B) and mef(A) in South Korea. J. Clin. Microbiol.
41: 5787-5791
[Abstract]
[Full Text]
Copyright © 2003 by the American Society for Microbiology. All rights reserved.